3Vincelot A,Nathan N,Collet D,et al. Platelet function during pregnancy: an evaluation using the PFA-100 aualyser. Br J Anaesth, 2001,81 (6) : 890- 893.
4Rodgers RP,Levin J.A critical reappraisal of the bleeding time[J].Se-min Thromb Hemost,1990,16(1):1-20.
4Taylor JR FB,Toh CH,Hoots WK,et al. Towards definition, clinical and laboratory criteria, and a scoring system for dissemi- nated intravascular coagulation-on behalf of the Scientific Sub- committee on disseminated intravascular coagulation(DIC) of the International Society on Thrombosis and Haemostasis(ISTH)[J]. Thromb Haemost,2001,86:1327-1230.
5Fenger-Eriksen C,Lindberg-Larsen M,Christensen AQ, et al. Fibrinogen concentrate substitution therapy in patients with mas- sive haemorrhage and low plasma fibrinogen concentrations [J]. Br J Anaesth,200$, 101(6) :769-773.
7Withagen MI,Wallenbury HC,Steegers EA,et al.Morbidityand development in childhood of infants born after temporisingtreat ment of early onset preeclampsia[J].BJOG,2005,112(7):910-914.
8Lakshmi RT,Priyanka T,Meenakshi J,et al.Lowmolecular weight heparin mediated regulation of nitric oxide synthase during burn wound healing[J].Ann Burns Fire Disasters,2011,24(1):24-29.
